Arylpiperazine derivatives and use thereof as 5-ht1a...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4985 (2006.01) A61P 25/00 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2582663

Novel substituted arylpiperazine derivatives with activity as 5- hydroxytryptamine 1A (5-HT1A ) receptor subtype ligands, to their stereochemical isomers, methods of their preparation, and to their use and to pharmaceutical compositions containing them for the treatment of Parkinson disease, cerebral damage by thromboembolic ictus, craneoencephalic traumatisms, depression, migraine, pain, psychosis, anxiety disorders, aggressive disorders or urinary tract disorders.

La présente invention concerne de nouveaux dérivés substitués d~arylpipérazine présentant une activité en tant que ligands du sous-type de récepteur de la 5-hydroxytryptamine 1A (5-HT1A ), à leurs stéréo-isomères, à des procédés de leur préparation, et à leur utilisation et à des compositions pharmaceutiques les contenant destinées au traitement de la maladie de Parkinson, des lésions cérébrales dues à un accident thrombo-embolique, des traumatismes crânio-encéphaliques, des dépressions, des migraines, des douleurs, des psychoses, des troubles de l~anxiété, des désordres agressifs ou des troubles du système urinaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Arylpiperazine derivatives and use thereof as 5-ht1a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arylpiperazine derivatives and use thereof as 5-ht1a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylpiperazine derivatives and use thereof as 5-ht1a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1857661

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.